Paragon Advisors, LLC Zoetis Inc. Transaction History

Paragon Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$181.39 - $234.03 $1.24 Million - $1.6 Million	-6,818 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$193.69 - $247.03 $1.32 Million - $1.68 Million	6,818 New	6,818 $1.66 Million
Q1 2021 Apr 12, 2021	SELL	$144.0 - $169.39 $893,376 - $1.05 Million	-6,204 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$157.07 - $174.35 $51,676 - $57,361	329 Added 5.6%	6,204 $1.02 Million
Q3 2020 Oct 30, 2020	BUY	$137.1 - $165.37 $4,798 - $5,787	35 Added 0.6%	5,875 $971,000
Q2 2020 Jul 07, 2020	SELL	$111.92 - $142.53 $261,780 - $333,377	-2,339 Reduced 28.6%	5,840 $800,000
Q1 2020 Apr 08, 2020	SELL	$92.66 - $144.94 $143,993 - $225,236	-1,554 Reduced 15.97%	8,179 $963,000
Q4 2019 Jan 14, 2020	BUY	$116.25 - $133.25 $1.13 Million - $1.3 Million	9,733 New	9,733 $1.32 Million

1,957

410M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Paragon Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Paragon Advisors, LLC with notifications on news.